More Globe Newswire

View Older Stories View Newer Stories

May 2, 2025 06:00PM Abaxx Files Early Warning Report with Respect to Base Carbon
May 2, 2025 05:49PM Dickey’s Builds Bigger Barbecue Flavor with New Smoke Stacks Menu
May 2, 2025 05:38PM Northfield Capital Engages Independent Trading Group As Market Maker
May 2, 2025 05:33PM Gran Tierra Energy Announces Final Voting Results of its Annual Meeting of Stockholders
May 2, 2025 05:30PM Conifex Announces First Quarter 2025 Results Conference Call
May 2, 2025 05:28PM District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia
May 2, 2025 05:27PM Oxbridge Re Announces 2025 First Quarter Results on May 12, 2025
May 2, 2025 05:20PM Hepsiburada Announces the Fourth Bond Issuance of Hepsifinans
May 2, 2025 05:01PM Mount Logan Capital Inc. Schedules Release of First Quarter 2025 Results
May 2, 2025 05:00PM Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 2, 2025 05:00PM Vital Battery Metals Announces Name Change to Aventis Energy
May 2, 2025 05:00PM Element Announces Annual Meeting Voting Results
May 2, 2025 04:45PM XCEL BRANDS, INC. Receives NASDAQ notice regarding late Form 10-K filing
May 2, 2025 04:42PM Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 2, 2025 04:30PM Beyond Oil Expands to Greece with New Distribution Agreement
May 2, 2025 04:30PM New Data at DDW 2025 Further Demonstrates the TissueCypher® Test's Ability to Identify Patients at Increased Risk for Developing Esophageal Cancer
May 2, 2025 04:30PM New Data at DDW 2025 Further Demonstrates the TissueCypher® Test's Ability to Identify Patients at Increased Risk for Developing Esophageal Cancer
May 2, 2025 04:30PM ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 2, 2025 04:30PM Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 2, 2025 04:30PM Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 2, 2025 04:30PM Result of General Meeting
May 2, 2025 04:24PM dvm360® unveils 2025–2026 Editorial Advisory Board: Fresh perspectives spark innovation across the veterinary field
May 2, 2025 04:15PM Microchip Technology Appoints Long-Time TSMC Executive Rick Cassidy to Its Board of Directors
May 2, 2025 04:15PM COMSTOCK RESOURCES, INC. ANNOUNCES DUAL LISTING ON NYSE TEXAS
May 2, 2025 04:15PM Credicorp Ltd.: Credicorp’s Earnings Release and Conference Call 1Q25
May 2, 2025 04:10PM NXP Announces Availability of Proxy Materials for the Annual General Meeting of Shareholders to Be Held on June 11, 2025
May 2, 2025 04:10PM Bon Natural Life Limited Announces Receipt of Nasdaq Delisting Notifications
May 2, 2025 04:08PM XRP News: Buy $XDX Tokens Now Before XenDex Presale Ends Soon, as XRP Market Heats Up
May 2, 2025 04:06PM Update on Market Making Arrangements
May 2, 2025 04:05PM PennantPark Investment Corporation Announces Monthly Distribution of $0.08 per Share
May 2, 2025 04:05PM Jushi Holdings Inc. Updates Call Time to 4:00 p.m. Eastern Time to Report First Quarter 2025 Financial Results on May 8, 2025
May 2, 2025 04:05PM NurExone Expands European Engagement with Investor Events in Germany and Switzerland
May 2, 2025 04:05PM PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share
May 2, 2025 04:05PM Taitron Announces Quarterly Cash Dividend
May 2, 2025 04:05PM Cipher Mining Announces April 2025 Operational Update
May 2, 2025 04:05PM U.S. Global Investors Announces Third Quarter of Fiscal 2025 Webcast
May 2, 2025 04:05PM Concorde International Group Announces Underwriter’s Full Exercise and Closing of Over-allotment Option
May 2, 2025 04:05PM Copley Acquisition Corp Announces Closing of $172,500,000 Initial Public Offering
May 2, 2025 04:05PM Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
May 2, 2025 04:05PM Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 2, 2025 04:05PM Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
May 2, 2025 04:05PM Greenlight Capital Re, Ltd. Schedules First Quarter 2025 Financial Results and Conference Call
May 2, 2025 04:01PM Iovance Biotherapeutics to Host First Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, May 8, 2025
May 2, 2025 04:01PM Premium Global Income Split Corp. Declares Monthly Distribution
May 2, 2025 04:01PM Premium Income Corporation Announces Monthly Distribution
May 2, 2025 04:01PM Mulvihill Premium Yield Fund Declares Monthly Fund Distribution for Its ETF Class
May 2, 2025 04:01PM Mulvihill Enhanced Split Preferred Share ETF Declares Monthly Distribution
May 2, 2025 04:01PM Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 2, 2025 04:01PM NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 2, 2025 04:01PM Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
View Newer Stories View Older Stories